Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221141 | SCV000269123 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Asp1468Asp in exon 25 of FLNC: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 2.7% (106/3868) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs2249128). |
Eurofins Ntd Llc |
RCV000221141 | SCV000338270 | benign | not specified | 2016-06-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001520069 | SCV001729080 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000221141 | SCV003929246 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000221141 | SCV001743812 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000221141 | SCV001921049 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000221141 | SCV001929019 | benign | not specified | no assertion criteria provided | clinical testing |